Observational studyBMC infectious diseases2026
Invasive Streptococcus dysgalactiae subsp. equisimilis infections in a super-aged society: a Japanese nationwide observational study (2024-2025).
Observational study in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical and Molecular Characteristics ofOpen forum infectious diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundStreptococcus dysgalactiae subsp. equisimilis (SDSE), historically considered less virulent than Streptococcus pyogenes, has emerged as an important invasive pathogen, particularly in aging societies. Data on nationwide clinical and molecular epidemiology in super-aged populations remain limited. We aimed to identify admission abnormalities associated with the 28-day mortality for invasive SDSE (iSDSE) infections in Japanese adults and evaluate the molecular epidemiology of this emerging pathogen through a large-scale surveillance.
methodsA prospective nationwide surveillance of iSDSE was conducted between March 2024 and March 2025 in 132 hospitals across Japan. Clinical, epidemiological, and laboratory data, including emm type distribution, were collected and analyzed.
resultsOverall, 278 patients with iSDSE infections were identified (median age, 83 years); one-quarter of the patients were residents of long-term care facilities. Nearly all patients had comorbidities. The 28-day mortality was 12.2% overall, which increased to 16.1% among patients aged ≥ 80 years. Fatal outcomes were strongly associated with bacteremic pneumonia and streptococcal toxic shock syndrome, whereas cellulitis showed a lower mortality burden. Intensive care unit admission, mechanical ventilation, and vasopressor use were more common in patients with fatal outcomes, reflecting disease severity. Variables associated with poor outcome included leukopenia, thrombocytopenia, and elevated levels of C-reactive protein, creatinine, and creatine kinase. Emm typing revealed stG6792 as the predominant lineage; however, a marked increase of stG840 was observed. No significant outcome differences were noted across emm types.
conclusionsThese findings emphasize the combined impact of advanced age, comorbid conditions, and critical illness on iSDSE outcomes, highlight the clinical burden of iSDSE in older adults, and support continued monitoring in Japan.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.